The results are completely private and use a web-based program to locate. This somewhat a first move of it’s type to be able to get a psychiatric genetic footprint before prescribing medications to treat various mental diseases/conditions to include medications for anti-depression. Anti-depression drugs have had some high failure rates and the test now offers doctors a new tool to aide in prescribing a medication that could be more suited to work, as there’s a lot of choices out there today.
The test must be ordered by a physician and the article states it takes around 48 hours for the results. BD
CINCINNATI, Oct. 22 /PRNewswire/ -- AssureRx, a personalized medicine company, announced today that it has begun a full launch of its first product, GeneSightRx(TM) This lab-developed, pharmacogenetic test had previously been commercially available only on a limited basis. The test combines state-of-the-art genetic testing technology with a multi-variate, algorithmic, interpretive report to help guide physicians during their decision-making process before prescribing psychiatric medications.
Al Lucas, VP Sales and Marketing, stated, "There is a significant challenge in psychiatric medicine to quickly find the most appropriate medication for each individual patient, which may bring relief from symptoms, reduce or prevent hospitalization, and avoid severe side-effects. Until recently, doctors had no way of identifying patients who may have genetic variations that would affect how medications might work in each patient."
The company was founded in June 2006 to commercialize industry-leading personalized medicine technology. Cincinnati Children's Hospital Medical Center and Mayo Clinic are equity holders and technology collaborators. More information on AssureRx visit: www.assurerxhealth.com.